-transparent.png){kind=logo}
Haloperidol levels were measured by radioreceptor assay in 12 schizophrenic patients during gradual dosage reduction (at 10-day) intervals) from 60 to 0 mg/day. Serum levels were highly correlated with the oral dose in each patient, but poorly correlated across patients. Clinical deterioration appeared only 10-20 days after total cessation of the oral drug, and so it was not possible to determine an optimal blood level for chronic maintenance. Below oral dosage of 10 mg/day of haloperidol many patients' blood levels are undetectable by the radioreceptor method.
Related Publications
Z Goldman, and
R P Ebstein, and
B Lerer, and
J Zohar, and
M Hermoni, and
R H Belmaker
February 1983,
Journal of clinical psychopharmacology,
Z Goldman, and
R P Ebstein, and
B Lerer, and
J Zohar, and
M Hermoni, and
R H Belmaker
June 1984,
Journal of clinical psychopharmacology,
Z Goldman, and
R P Ebstein, and
B Lerer, and
J Zohar, and
M Hermoni, and
R H Belmaker
January 1988,
Journal of psychopharmacology (Oxford, England),
Z Goldman, and
R P Ebstein, and
B Lerer, and
J Zohar, and
M Hermoni, and
R H Belmaker
June 1989,
Journal of clinical psychopharmacology,
Z Goldman, and
R P Ebstein, and
B Lerer, and
J Zohar, and
M Hermoni, and
R H Belmaker
February 1985,
Biological psychiatry,
Z Goldman, and
R P Ebstein, and
B Lerer, and
J Zohar, and
M Hermoni, and
R H Belmaker
February 1986,
Journal of clinical psychopharmacology,
Z Goldman, and
R P Ebstein, and
B Lerer, and
J Zohar, and
M Hermoni, and
R H Belmaker
January 1993,
Psychopharmacology bulletin,
Z Goldman, and
R P Ebstein, and
B Lerer, and
J Zohar, and
M Hermoni, and
R H Belmaker
August 1984,
Journal of clinical psychopharmacology,
Z Goldman, and
R P Ebstein, and
B Lerer, and
J Zohar, and
M Hermoni, and
R H Belmaker
July 1986,
The Journal of clinical psychiatry,
Z Goldman, and
R P Ebstein, and
B Lerer, and
J Zohar, and
M Hermoni, and
R H Belmaker
January 1980,
Psychopharmacology,
